Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A KAPLAN

Showing results (91-100 of 2,545) with videos related to

Pageof 255
Sort By:
The Journal of Urology|February 14, 2012
Re: increased risk of benign prostatic enlargement among patients with liver cirrhosis: a nationwide population-based studySteven A Kaplan
The Journal of Urology|January 13, 2012
Re: clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trialSteven A Kaplan
The Journal of Urology|January 13, 2012
Re: comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS)Steven A Kaplan
The Journal of Urology|November 16, 2011
Re: Long-Term Treatment and Prognostic Factors of alpha1-Blockers for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Pilot Study Comparing Naftopidil and Tamsulosin HydrochlorideSteven A Kaplan
Annals of the New York Academy of Sciences|February 22, 2000
What is the role of the social environment in understanding inequalities in health?G A Kaplan
Seminars in Dialysis|October 3, 2000
Dialyzer reuse: what we know and what we don't knowA A Kaplan
Journal of Cardiothoracic and Vascular Anesthesia|April 20, 2001
Online and enhancedJ A Kaplan
The Journal of Urology|November 12, 2019
Re: Laser Prostate Ablation and Enucleation: Analysis of a National CohortSteven A Kaplan
The Journal of Urology|November 12, 2019
Re: Alpha-Blockers with or without Phosphodiesterase Type 5 Inhibitor for Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-AnalysisSteven A Kaplan
The Journal of Urology|March 18, 2020
Re: Impact of Metabolic Syndrome-Related Factors on the Development of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms in Asian PopulationSteven A Kaplan
Pageof 255

Showing results (91-100 of 2,545) with videos related to

Sort By:
Pageof 255
The Journal of Urology|February 14, 2012
Re: increased risk of benign prostatic enlargement among patients with liver cirrhosis: a nationwide population-based studySteven A Kaplan
The Journal of Urology|January 13, 2012
Re: clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trialSteven A Kaplan
The Journal of Urology|January 13, 2012
Re: comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS)Steven A Kaplan
The Journal of Urology|November 16, 2011
Re: Long-Term Treatment and Prognostic Factors of alpha1-Blockers for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Pilot Study Comparing Naftopidil and Tamsulosin HydrochlorideSteven A Kaplan
Annals of the New York Academy of Sciences|February 22, 2000
What is the role of the social environment in understanding inequalities in health?G A Kaplan
Seminars in Dialysis|October 3, 2000
Dialyzer reuse: what we know and what we don't knowA A Kaplan
Journal of Cardiothoracic and Vascular Anesthesia|April 20, 2001
Online and enhancedJ A Kaplan
The Journal of Urology|November 12, 2019
Re: Laser Prostate Ablation and Enucleation: Analysis of a National CohortSteven A Kaplan
The Journal of Urology|November 12, 2019
Re: Alpha-Blockers with or without Phosphodiesterase Type 5 Inhibitor for Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-AnalysisSteven A Kaplan
The Journal of Urology|March 18, 2020
Re: Impact of Metabolic Syndrome-Related Factors on the Development of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms in Asian PopulationSteven A Kaplan
Pageof 255